Ind-Swift Laboratories balance sheet

As of Sep 2026

Total assets: ₹1,771cr+14.7% on Sep 2025
Shareholders' equity: ₹1,474cr+12.8% on Sep 2025
Total debt: ₹19.6cr−10.4% on Sep 2025
Cash and investments: ₹385cr−8.1% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	274	275	260	5.4	583
	39.8	10.2	—	—	7.7
	2.2	2.2	2.3	2.3	2.4
	34.9	25.2	10.7	0.0	1.9
	2.0	2.2	—	—	0.0
	236	236	174	111	30.3
	73.5	73.5	73.5	0.0	0.0
	2.2	2.7	2.1	0.5	3.2
	312	312	250	111	33.6
	50.4	50.3	44.6	31.9	29.9
	33.6	19.4	5.6	353	1.0
	748	697	573	504	660
	170	148	114	10.5	439
	45.0	11.9	39.4	0.0	0.0
	245	199	165	169	505
	340	430	428	432	18.2
	33.7	30.1	14.2	—	27.0
	664	670	646	601	550
	189	158	105	49.6	175
	1,023	977	865	661	1,165
	1,771	1,673	1,438	1,165	1,824
Equity
	87.0	86.8	68.7	59.1	59.8
	1,387	1,297	1,104	872	622
	1,474	1,384	1,173	931	682
	−0.1	−0.1	−0.0	−0.0	0.0
	1,474	1,384	1,173	931	682
Liabilities
	15.2	12.3	25.7	11.2	753
	0.2	2.6	0.2	—	0.5
	15.4	14.9	25.9	11.2	753
	13.6	13.1	11.4	1.2	17.8
	5.8	6.7	7.5	—	0.1
	34.7	34.7	44.8	12.4	771
	4.4	5.6	14.9	5.5	109
	136	146	110	94.0	204
	1.6	0.0	0.0	—	5.0
	141	151	125	99.4	318
	2.8	2.8	1.8	102	12.3
	6.3	0.1	4.2	—	0.0
	112	100	89.4	20.1	40.9
	262	255	221	221	371
	297	289	265	234	1,142
	1,771	1,673	1,438	1,165	1,824
Trade payables — MSME split
	0.8	9.8	5.9	—	—
	135	136	104	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

INDSWFTLAB₹409.80

Ind-Swift Laboratories Limited

· Pharma & Health

₹ CrorePeersSMSPHARMA SOLARA DCAL HIKAL UNICHEMLAB GUFICBIO PANACEABIO RPGLIFEMcap ₹3,559 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	583.2	5.4	260.1	275.1	273.5
+ Capital Work-in-Progress	7.7	—	—	10.2	39.8
+ Investment Property	2.4	2.3	2.3	2.2	2.2
+ Other Intangibles	1.9	0.0	10.7	25.2	34.9
+ Intangibles under Development	0.0	—	—	2.2	2.0
+ Non-current Investments	30.3	110.5	174.1	235.6	236.3
+ Long-term Loans	0.0	0.0	73.5	73.5	73.5
+ Other Non-current Financial Assets	3.2	0.5	2.1	2.7	2.2
Non-current Financial Assets	33.6	111.0	249.7	311.9	312.1
+ Deferred Tax Assets	29.9	31.9	44.6	50.3	50.4
+ Other Non-current Assets	1.0	353.4	5.6	19.4	33.6
Total Non-current Assets	659.5	504.0	573.0	696.6	748.5
Current Assets
+ Inventories	438.6	10.5	114.2	147.9	170.1
+ Current Investments	0.0	0.0	39.4	11.9	45.0
+ Trade Receivables	505.3	169.1	164.5	198.5	245.1
+ Cash & Cash Equivalents	18.2	431.9	428.0	429.8	340.4
+ Other Current Financial Assets	27.0	—	14.2	30.1	33.7
Current Financial Assets	550.5	601.0	646.2	670.4	664.2
+ Other Current Assets	175.4	49.6	105.0	158.4	188.5
Total Current Assets	1,164.5	661.1	865.3	976.8	1,022.7
Total Assets	1,824.1	1,165.1	1,438.3	1,673.3	1,771.2
Equity
+ Equity Share Capital	59.8	59.1	68.7	86.8	87.0
+ Other Equity / Reserves	622.1	872.4	1,104.3	1,297.2	1,387.4
Equity — Owners of Parent	681.9	931.5	1,173.0	1,384.0	1,474.4
+ Minority Interest	0.0	-0.0	-0.0	-0.1	-0.1
Total Equity	681.9	931.4	1,173.0	1,384.0	1,474.3
Liabilities
+ Borrowings — Non-current	752.6	11.2	25.7	12.3	15.2
+ Other Non-current Financial Liab	0.5	—	0.2	2.6	0.2
Non-current Financial Liabilities	753.1	11.2	25.9	14.9	15.4
+ Provisions — Non-current	17.8	1.2	11.4	13.1	13.6
+ Other Non-current Liabilities	0.1	—	7.5	6.7	5.8
Non-current Liabilities	771.0	12.4	44.8	34.7	34.7
+ Borrowings — Current	108.9	5.5	14.9	5.6	4.4
+ Trade Payables	204.0	94.0	110.2	145.9	135.5
+ Other Current Financial Liab	5.0	—	0.0	0.0	1.6
Current Financial Liabilities	317.9	99.4	125.2	151.5	141.5
+ Provisions — Current	12.3	101.8	1.8	2.8	2.8
+ Current Tax Liabilities	0.0	—	4.2	0.1	6.3
+ Other Current Liabilities	40.9	20.1	89.4	100.4	111.6
Current Liabilities	371.1	221.3	220.6	254.7	262.1
Total Liabilities	1,142.1	233.7	265.4	289.4	296.9
Total Equity & Liabilities	1,824.1	1,165.1	1,438.3	1,673.3	1,771.2
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	5.9	9.8	0.8
+ Dues to Other Creditors — Current	—	—	104.4	136.1	134.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.